| Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More | Alex Lash | 07/29/16 | National |
| LabCorp Boosts Prenatal Testing Presence with $371M Sequenom Deal | Frank Vinluan | 07/27/16 | Raleigh Durham |
| West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags | Alex Lash | 12/04/15 | San Francisco |
| Epic Sciences Names Dave Henderson as CIO | Bruce V. Bigelow | 08/26/15 | San Diego |
| Prenatal Tester Natera Now Shooting for $175M IPO | Alex Lash | 07/01/15 | San Francisco |
| Preeclampsia Test Developer Carmenta Bought For Undisclosed Sum | Alex Lash | 04/29/15 | San Francisco |
| Prenatal Screener Natera Grabs $55M, Considers Cancer Test | David Holley | 04/06/15 | San Francisco |
| West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More | Alex Lash | 01/29/15 | San Francisco |
| West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More | Alex Lash | 09/04/14 | San Diego |
| West Coast Biotech Roundup: NanoString, Sequenom/Agena, CIRM, & More | Alex Lash | 06/06/14 | San Diego |
| Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO | Ben Fidler | 03/25/14 | San Francisco |
| San Diego Life Sciences Roundup: Acadia, Ignyta, Tracon, & More | Bruce V. Bigelow | 03/07/14 | San Diego |
| San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More | Bruce V. Bigelow | 02/28/14 | San Diego |
| Miscarriage Mysteries Create New Market for Natera | Bernadette Tansey | 02/12/14 | San Francisco |
| San Diego Life Sciences Roundup: Fate, Ligand, BioNano, and More | Bruce V. Bigelow | 10/04/13 | San Diego |
| San Diego Life Sciences Roundup: Evoke, Halozyme, Biocept, and More | Bruce V. Bigelow | 09/27/13 | San Diego |
| Foundation’s IPO Isn’t Bubbly, It’s a Jolt for Genomic Diagnostics | Steve Dickman | 09/25/13 | Boston |
| San Diego Life Sciences Roundup: Vical, Sequenom, Sophiris, and More | Bruce V. Bigelow | 08/23/13 | San Diego |
| Cellscape Hunts for Fetal Cells in Mom, Pushing Diagnostic Frontier | Luke Timmerman | 08/21/13 | San Francisco |
| Sequenom Discloses 75 Layoffs as Part of Cost-Cutting Reorganization | Bruce V. Bigelow | 08/19/13 | San Diego |
| San Diego Life Sciences News: Trius, Optimer, aTyr, Ligand, and More | Bruce V. Bigelow | 08/01/13 | San Diego |
| San Diego Tech Week Reflects Gains as Web Startups Amass Downtown | Bruce V. Bigelow | 07/02/13 | San Diego |
| Natera Grabs $55M For Push into Prenatal Genetic Screening | Luke Timmerman | 05/01/13 | San Francisco |
| San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More | Bruce V. Bigelow | 02/21/13 | San Diego |
| Natera Joins Quest in Four-Way Battle for Prenatal Genetic Tests | Luke Timmerman | 02/20/13 | San Francisco |
| Illumina CEO Jay Flatley on Diagnostics, the $1K Genome & China | Luke Timmerman | 01/15/13 | San Diego |
| Illumina Acquires Verinata Health, Prenatal Testmaker, For $350M | Luke Timmerman | 01/07/13 | San Diego |
| San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More | Bruce V. Bigelow | 10/05/12 | San Diego |
| Verinata’s Big Day Arrives, With Prenatal Down Syndrome Test Debut | Luke Timmerman | 02/29/12 | San Francisco |
| San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More | Bruce V. Bigelow | 01/26/12 | San Diego |
